Teva sees 15 drug applications from 2009-2015
446709
Teva Pharmaceutical Industries Ltd.  said on Tuesday it could file 15 applications between 2009-2015  seeking approval for either new medicines, or for new uses or  stronger dosages for its drugs.
269527
Teva Pharmaceuticals of Israel, the largest generic-drug maker in the world, announced yesterday that it was acquiring the Rockville biotechnology company CoGenesys for $400 million.
670469
Cipla and Ranbaxy Laboratories agreed to make 19 different anti-retroviral drugs designed for children available at an average price of 16 cents a day, or $60 a year.
683607
AtheroGenics announces the path forward for its lead drug.
535175
BioSante releases more info on the pivotal studies for its lead drug.
420195
Medarex's lead drug gets an important yet expected designation from the FDA.
154593
In the wake of the expansion of the European Union with 10 additional states, attention has been fixed on the development of the pharmaceutical industry in these and other Eastern European states.
137354
The Food and Drug Administration announced Friday its intentions to conduct a major evaluation of its approach in dealing with safety concerns involving drugs, primarily those that are already marketed.
147168
The approval of a new drug is a long-term opportunity.
182775
Florida will create 4,500 new biopharmaceutical jobs in the next 10 years as the industry grows significantly across the nation, according to a report released today by the Milken Institute in Los Angeles.
50076
PRETORIA -- Ranbaxy Laboratories in India withdrew seven antiretroviral drugs for AIDS patients last month from the World Health Organization list of prequalified medicines. The company acknowledged that it did not complete proper lab tests to make sure its copycat drugs were equivalent with brand-name ones.
729582
Biopharmaceutical company Medarex Inc. and Bristol-Myers Squibb Co., the maker of Excedrin and Bufferin headache medicines, on Monday said they have teamed to develop and market MDX-010, an experimental drug for the treatment of melanoma.
601819
Merck & Co. on Tuesday said it aims to  seek U.S. approvals next year for drugs to treat HIV,  cholesterol and insomnia and aims to have another four products  in late-stage trials by mid-2007.
155751
NEW YORK/WHITEHOUSE STATION, New Jersey  - Merck & Co.  expects to seek U.S. approval in 2007 for drugs to treat HIV, cholesterol and insomnia, and it aims to have another four products in late-stage trials by mid-year, the company said on Tuesday.
374108
Drug giant Novartis AG says it will give its Cambridge neighbor, MIT, $65 million over 10 years to create a research program, likely to be the biggest in the world aimed at revolutionizing the way drugs are made.
143325
Swiss drugmaker Roche Holding AG is  taking legal action against Israel&#39;s Teva Pharmaceutical  Industries Ltd  in the United States to prevent Teva  from selling a generic version of Roche osteoporosis drug  Boniva, Roche said on Tuesday.
438501
Here's what a newly approved drug looks like.